%20(3)_edited_edited_edi.png)
Let Your Data Drive Your Clinical Research
At CiNTL Pharma, we understand the importance of data in clinical research.
We use agentic workflows that connect science, data, and execution, helping sponsors deliver therapies to patients faster, safer, and smarter.
We provide customized solutions to meet the unique needs of each client, ensuring that their research is conducted efficiently and effectively and to the highest degree of integrity.
%20(3)_edited_edited_edited.png)
Versatility in Clinical Research Applications
CiNTL Pharma provides a wide range of clinical research services, including medical writing, regulatory submissions, clinical monitoring, and site management. We have experience working with a variety of therapeutic areas and study designs, and we are committed to delivering high-quality results.
Full-Service Clinical Research Solutions
Offering end-to-end clinical research solutions, from study design to final report. Our team of experts has extensive experience in managing clinical trials and can provide customized solutions to meet our clients' unique needs.
Clinical Data Analytics
Everything we do is built to get medicines to patients faster. We combine data analytics to support better-informed decisions and more efficient clinical trials, to the highest industry and regulatory standards.
Data Science for Clinical Research
Our team of data scientists specializes in clinical research and provides advanced statistical analysis and modeling. We help our clients make sense of their data, identify trends, and make data-driven decisions.
Unprecedented Velocity. Impeccable Reliability.
CiNTL Pharma is committed to providing our clients with high-quality outsourced clinical research services. Our team of experts uses the latest technology to drive speed and delivery. We offer a wide range of services, including R&D, risk-based clinical monitoring, project and data management, and statistical analysis, from inception to completion. Complex clinical trial projects are our forte.
The Latest at CiNTL Pharma
-2.jpg){kind=small}
01 - Oct - 2026
CiNTL Pharma B.V. today announced that its CEO, Yolanda Cabrera-Sybesma, MPH, will be a keynote speaker at AUTOMA+ 2026, the Pharmaceutical Automation and Digitalisation Congress, taking place on 16–17 November 2026 in Zürich, Switzerland.
AUTOMA+ brings together leaders from across the pharmaceutical industry to explore how automation, AI, digital R&D, smart manufacturing, data, and supply-chain technologies are shaping the future of pharma.
CiNTL Pharma looks forward to connecting with industry leaders, exploring new business opportunities, and turning digital innovation into real-world impact across pharma.
25 Sep - 2026
CiNTL Pharma B.V. today shared that its CEO, Yolanda Cabrera-Sybesma, MPH, delivered a guest lecture at Rotterdam School of Management, Erasmus University, as part of the Positive Impact Seminar for students in the MSc Management of Innovation and Medical Business & Innovation programmes.
Her lecture, “Engineering Positive Impact in the Age of AI: From personal conviction to systems that change how medicine reaches patients,” shared CiNTL Pharma's journey in building a fully Agentic Clinical Tower platform, grounded in decades of clinical and regulatory expertise and designed to help sponsors run clinical trials in Europe and beyond more efficiently.
Her message to future healthcare innovators: technology scales impact, but domain knowledge makes it trustworthy.
22 - Sep - 2026
CiNTL Pharma B.V. today shared that its CEO, Yolanda Cabrera-Sybesma, MPH, participated in the Keynote C-Suite Panel at COG: CRO Summit Europe 2026 in Amsterdam. The session, “European Clinical Research Renaissance: Strengthening the Continent's Position in Global Trials,” brought together senior leaders from European CROs to discuss how Europe can strengthen its position as a preferred destination for global clinical research.
The conversation explored the evolving EMA regulatory environment, healthcare infrastructure, patient recruitment and data capabilities, investment priorities, and the competitive advantages that can help Europe attract international sponsors while supporting faster, high-quality, and innovative clinical trial delivery.
CiNTL Pharma thanks the organizers and fellow panellists for an engaging discussion on the collaboration needed to further strengthen Europe's role in global trials.
It's all about the data
75+
Years of Combined Experience
180
Trials Supported
80,000
Patients Enrolled
9
Therapeutic Areas + Medical Devices
5
Continents
Our Team's Combined Experience
Meet Us at an Event
